pyridostigmine
CAS No. 155-97-5
pyridostigmine( Pyridostigminum,Regonol,Mestinon-SR )
Catalog No. M22264 CAS No. 155-97-5
Pyridostigmine is an acetylcholinesterase inhibitor that can treat myasthenia gravis by increasing acetylcholine at the postsynaptic motor endplate.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 162 | In Stock |
|
| 5MG | 170 | In Stock |
|
| 10MG | 258 | In Stock |
|
| 25MG | 426 | In Stock |
|
| 50MG | 586 | In Stock |
|
| 100MG | 792 | In Stock |
|
| 200MG | 1051 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Namepyridostigmine
-
NoteResearch use only, not for human use.
-
Brief DescriptionPyridostigmine is an acetylcholinesterase inhibitor that can treat myasthenia gravis by increasing acetylcholine at the postsynaptic motor endplate.
-
DescriptionPyridostigmine is an acetylcholinesterase inhibitor that can treat myasthenia gravis by increasing acetylcholine at the postsynaptic motor endplate.Pyridostigmine holds promise for the treatment of various gastrointestinal symptoms in SSc patients, particularly in patients with refractory constipation. Though side effects may limit its use, most patients who experienced benefit chose to continue therapy.
-
In Vitro——
-
In Vivo——
-
SynonymsPyridostigminum,Regonol,Mestinon-SR
-
PathwayOthers
-
TargetOther Targets
-
Recptoracetylcholinesterase
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number155-97-5
-
Formula Weight261.12
-
Molecular FormulaC9H13BrN2O2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCN(C)C(=O)Oc1ccc[n+](C)c1.[Br-]
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
Bruceantinol A
Bruceantinol A is a natural product from Brucea javanica.
-
2,3-Dihydrofuran
2,3-Dihydrofuran is a heterocyclic compound. It is one of the simplest enol ethers.
-
Eugeniin
Tellimagrandin II (Eugeniin), with oral activity, is the first intermediate of the ellagitannin series derived from 4C1-glucose. It inhibits the resistance of Staphylococcus aureus by disrupting the integrity of the cell wall, leading to the loss of cytoplasmic contents. Additionally, Tellimagrandin II exhibits anti-inflammatory effects and inhibits acetylcholinesterase (AChE) activity, improving memory impairment. Tellimagrandin II holds potential for research in the fields of antibacterial, anti-inflammatory, and neurodegenerative diseases.
Cart
sales@molnova.com